Detalhe da pesquisa
1.
Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies.
Arterioscler Thromb Vasc Biol
; 44(5): 1156-1164, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38545781
2.
Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials.
Diabetes Obes Metab
; 2024 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38757725
3.
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
Eur Heart J
; 44(2): 129-138, 2023 01 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36331326
4.
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.
Eur Heart J
; 44(25): 2277-2291, 2023 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37130090
5.
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study.
Lancet
; 399(10326): 719-728, 2022 02 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35101175
6.
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia.
N Engl J Med
; 382(16): 1520-1530, 2020 04 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32197277
7.
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
N Engl J Med
; 382(16): 1507-1519, 2020 04 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32187462
8.
Evinacumab for Homozygous Familial Hypercholesterolemia.
N Engl J Med
; 383(8): 711-720, 2020 08 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32813947
9.
Effect of inclisiran on lipids in primary prevention: the ORION-11 trial.
Eur Heart J
; 43(48): 5047-5057, 2022 12 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36331315
10.
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis.
Curr Atheroscler Rep
; 24(12): 959-967, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36367663
11.
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials.
Cardiovasc Drugs Ther
; 2022 Dec 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36550348
12.
Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia.
Curr Opin Lipidol
; 32(4): 213-218, 2021 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33883446
13.
Management of familial hypercholesterolemia in pregnancy.
Curr Opin Lipidol
; 32(6): 370-377, 2021 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34619689
14.
Poor cardiovascular health is associated with subclinical atherosclerosis in apparently healthy sub-Saharan African populations: an H3Africa AWI-Gen study.
BMC Med
; 19(1): 30, 2021 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33563289
15.
Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.
Arterioscler Thromb Vasc Biol
; 40(11): 2747-2755, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32878475
16.
Regression of cutaneous xanthomata in patient with homozygous familial hypercholesterolemia using novel therapies.
Lancet
; 402(10404): e11, 2023 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37659780
17.
Hyperpigmentation from Addison's Disease.
N Engl J Med
; 384(18): 1752, 2021 May 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33951364
18.
Evinacumab for Homozygous Familial Hypercholesterolemia. Reply.
N Engl J Med
; 384(6): e17, 2021 02 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33567208
19.
Lomitapide and Mipomersen-Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis.
Curr Atheroscler Rep
; 21(12): 48, 2019 11 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31741187
20.
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.
Arterioscler Thromb Vasc Biol
; 38(3): 592-598, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29284604